Unraveling the Power of Zaleplon Laden MCM-41 Silica Nano-carriers: In Vitro and In Vivo Assessment for Insomnia Treatment-Reference-Cited by-同舟云学术

Unraveling the Power of Zaleplon Laden MCM-41 Silica Nano-carriers: In Vitro and In Vivo Assessment for Insomnia Treatment

Published:2024-06-27 Issue: Volume: Page:
ISSN:2191-1630
Container-title:BioNanoScience
language:en
Short-container-title:BioNanoSci.

Author:

Pandya Vidhi,Trivedi Nidhi,Patel Amit A.,Prajapati Bhupendra G.,Patel Samir G.,Patel Archita,Solanki Vanraj,Patel Alkesh,Patel Preyash,Zinzuvadia Diwayanshi,Patel Ravish J.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12668-024-01509-7.pdf

Reference35 articles.

1. Kathleen, B., & Bailes, R. (2010). Insomnia in Adults_ Etiology and management. The Journal for Nurse Practitioners, 6(1), 53–60. https://doi.org/10.1016/j.nurpra.2009.09.013

2. Khalifa, M. K. A., Salem, H. A., Shawky, S. M., Eassa, H. A., & Elaidy, A. M. (2019). Enhancement of zaleplon oral bioavailability using optimized self-nano emulsifying drug delivery systems and its effect on sleep quality among a sample of psychiatric patients. Drug Delivery, 26(1), 1243–1253. https://doi.org/10.1080/10717544.2019.1687613

3. Almeneessier, A. S., Gupta, R., Pandi-Perumal, S. R., & BaHammam, A. S. (2019). Overview of sleep disorders. The behavioral, molecular, pharmacological, and clinical basis of the sleep-wake cycle (pp. 103–122). https://doi.org/10.1016/B978-0-12-816430-3.00006-3

4. Kirkwood, C. K. (1999). Management of insomnia. Journal of the American Pharmaceutical Association (Washington, D.C. : 1996), 39(5), 10533351. https://doi.org/10.1016/s1086-5802(15)30354-5

5. Weitzel, K. W., Wickman, J. M., Augustin, S. G., & Strom, J. G. (2000). Zaleplon: A pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia. Clinical therapeutics, 22(11), 1254–1267. https://doi.org/10.1016/S0149-2918(00)83024-6